-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Adverum Biotechnologies, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2024.
- Adverum Biotechnologies, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$42.6M, a 58.1% decline year-over-year.
- Adverum Biotechnologies, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$139M, a 7.92% decline year-over-year.
- Adverum Biotechnologies, Inc. annual Operating Income (Loss) for 2024 was -$139M, a 7.92% decline from 2023.
- Adverum Biotechnologies, Inc. annual Operating Income (Loss) for 2023 was -$129M, a 17.9% increase from 2022.
- Adverum Biotechnologies, Inc. annual Operating Income (Loss) for 2022 was -$157M, a 7.54% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)